about
Tamoxifen therapy benefit for patients with 70-gene signature high and low risk.Use of Molecular Tools to Identify Patients With Indolent Breast Cancers With Ultralow Risk Over 2 Decades.Prognostic value of PAM50 and risk of recurrence score in patients with early-stage breast cancer with long-term follow-up.
P2860
description
2017 nî lūn-bûn
@nan
2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
A breast cancer gene signature for indolent disease.
@ast
A breast cancer gene signature for indolent disease.
@en
type
label
A breast cancer gene signature for indolent disease.
@ast
A breast cancer gene signature for indolent disease.
@en
prefLabel
A breast cancer gene signature for indolent disease.
@ast
A breast cancer gene signature for indolent disease.
@en
P2093
P2860
P1476
A breast cancer gene signature for indolent disease.
@en
P2093
Anke Witteveen
Caroline A Drukker
Christa Dreezen
Inès J Beumer
Laura J Van't Veer
Leonie J M J Delahaye
M William Audeh
Mireille Snel
Rene Bernards
P2860
P2888
P304
P356
10.1007/S10549-017-4262-0
P407
P577
2017-04-27T00:00:00Z
P6179
1085077980